CPDA-1 209 mg/70mL (Anticoagulant Citrate Phosphate Dextrose Adenine SOLUTION) 209 mg/70mL

CPDA-1 209 mg/70mL is an anticoagulant solution used to preserve blood components. This intravenous solution contains citrate, phosphate, dextrose, and adenine, ensuring blood viability during storage.

Strength

209 mg/70mL

Pack Size

70 mL in 1 BAG (0942-6320-02)

Manufacturer / TM Owner

Fenwal, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

CPDA-1 209 mg/70mL is primarily used to prevent blood clotting in collected blood. This solution is designed to maintain the quality and viability of blood components, such as red blood cells, during storage. It is commonly used in medical settings where blood preservation is necessary, such as blood banks and hospitals. The solution helps extend the shelf life of blood products, ensuring they remain viable for transfusion.

Side Effects

CPDA-1 209 mg/70mL works by inhibiting the clotting process, allowing blood to be stored safely. The solution contains citrate, which binds calcium ions and prevents coagulation. Phosphate and dextrose provide nutrients to maintain red blood cell metabolism, while adenine helps preserve the energy levels of the cells. These combined effects ensure that the blood remains viable for a longer period.

Precautions & Warnings

CPDA-1 209 mg/70mL should be handled with care to maintain sterility. It is important to follow proper storage guidelines to ensure the solution remains effective. The solution should be stored at the appropriate temperature and protected from light. Always check the expiration date before use. Ensure that the solution is administered by trained medical professionals to avoid any complications.

Avoid Interactions

CPDA-1 209 mg/70mL may interact with certain medications or substances. It is important to inform healthcare providers about any other medications being taken. The solution should not be mixed with other solutions unless specifically instructed by a medical professional. Always follow the guidelines provided by the manufacturer and healthcare providers to ensure safe and effective use.

Frequently Asked Questions

CPDA-1 209 mg/70mL is used to preserve blood components by preventing clotting during storage.

It contains citrate, phosphate, dextrose, and adenine to inhibit clotting and maintain blood cell viability.

The solution prevents blood clotting and provides nutrients to maintain red blood cell metabolism and energy levels.

It should be stored at the appropriate temperature and protected from light to maintain its effectiveness.

It should not be mixed with other solutions unless specifically instructed by a medical professional.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.